| 1 |
Kodam P, Sai Swaroop R, Pradhan SS, Sivaramakrishnan V, Vadrevu R. Integrated multi-omics analysis of Alzheimer's disease shows molecular signatures associated with disease progression and potential therapeutic targets. Sci Rep 2023;13:3695. [PMID: 36879094 DOI: 10.1038/s41598-023-30892-6] [Reference Citation Analysis]
|
| 2 |
Arambula AM, Gu S, Warnecke A, Schmitt HA, Staecker H, Hoa M. In Silico Localization of Perilymph Proteins Enriched in Meńier̀e Disease Using Mammalian Cochlear Single-cell Transcriptomics. Otology & Neurotology Open 2023;3:e027. [DOI: 10.1097/ono.0000000000000027] [Reference Citation Analysis]
|
| 3 |
Fan Q, Xiao K, Ruhan A, Gao L, Wu Y, Chen D, Hu C, Jia X, Liu C, Liu X, Cao C, Shi Q, Dong X. Accumulation of prion triggers the enhanced glycolysis via activation of AMKP pathway in prion infected rodent and cell models.. [DOI: 10.21203/rs.3.rs-2595947/v1] [Reference Citation Analysis]
|
| 4 |
Tiwari P, Tolwinski NS. Using Optogenetics to Model Cellular Effects of Alzheimer's Disease. Int J Mol Sci 2023;24. [PMID: 36901729 DOI: 10.3390/ijms24054300] [Reference Citation Analysis]
|
| 5 |
Ahmad I, Singh R, Pal S, Prajapati S, Sachan N, Laiq Y, Husain H. Exploring the Role of Glycolytic Enzymes PFKFB3 and GAPDH in the Modulation of Aβ and Neurodegeneration and Their Potential of Therapeutic Targets in Alzheimer's Disease. Appl Biochem Biotechnol 2023. [PMID: 36692648 DOI: 10.1007/s12010-023-04340-0] [Reference Citation Analysis]
|
| 6 |
Dalmasso MC, Arán M, Galeano P, Perin S, Giavalisco P, Martino Adami PV, Novack GV, Castaño EM, Cuello AC, Scherer M, Maier W, Wagner M, Riedel-Heller S, Ramirez A, Morelli L. Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics. Front Mol Biosci 2022;9:1067296. [PMID: 36685284 DOI: 10.3389/fmolb.2022.1067296] [Reference Citation Analysis]
|
| 7 |
Hu D, Jin Y, Hou X, Zhu Y, Chen D, Tai J, Chen Q, Shi C, Ye J, Wu M, Zhang H, Lu Y. Application of Marine Natural Products against Alzheimer's Disease: Past, Present and Future. Mar Drugs 2023;21. [PMID: 36662216 DOI: 10.3390/md21010043] [Reference Citation Analysis]
|
| 8 |
Wang X, Zhou X, Lee J, Furdui CM, Ma T. In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis 2023;91:1471-82. [PMID: 36641677 DOI: 10.3233/JAD-221044] [Reference Citation Analysis]
|
| 9 |
Verma A, Shteinfer-Kuzmine A, Kamenetsky N, Pittala S, Paul A, Nahon Crystal E, Ouro A, Chalifa-Caspi V, Pandey SK, Monsonego A, Vardi N, Knafo S, Shoshan-Barmatz V. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology. Transl Neurodegener 2022;11:58. [PMID: 36578022 DOI: 10.1186/s40035-022-00329-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbé D, Movassat J. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets. Int J Mol Sci 2022;23. [PMID: 36499613 DOI: 10.3390/ijms232315287] [Reference Citation Analysis]
|
| 11 |
Reale M, Costantini E, Aielli L, Di Giuseppe F, Angelucci S, Kamal MA, Greig NH. Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging. Int J Mol Sci 2022;23. [PMID: 36499421 DOI: 10.3390/ijms232315097] [Reference Citation Analysis]
|
| 12 |
Deolankar SC, Najar MA, Ramesh P, Kanichery A, Kudva AK, Raghu SV, Prasad TSK. Discovery of Molecular Networks of Neuroprotection Conferred by Brahmi Extract in Aβ42-Induced Toxicity Model of Drosophila melanogaster Using a Quantitative Proteomic Approach. Mol Neurobiol 2022. [PMID: 36261695 DOI: 10.1007/s12035-022-03066-0] [Reference Citation Analysis]
|
| 13 |
Islam M, Behura SK. Role of Caveolin 1 in metabolic programming of fetal brain.. [DOI: 10.1101/2022.10.18.512714] [Reference Citation Analysis]
|
| 14 |
Shen W, Elahi M, Wang B, Zhan M, Yang P, Yang P. Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer’s Disease Neuropathology. JAD 2022. [DOI: 10.3233/jad-215687] [Reference Citation Analysis]
|
| 15 |
Kim J, Kang S, Chang K. Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model. IJMS 2022;23:10602. [DOI: 10.3390/ijms231810602] [Reference Citation Analysis]
|
| 16 |
Ohno K, Abdelhamid M, Zhou C, Jung C, Michikawa M. Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice. JAD 2022. [DOI: 10.3233/jad-220479] [Reference Citation Analysis]
|
| 17 |
Kumar V, Kim S, Bishayee K. Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions. IJMS 2022;23:9540. [DOI: 10.3390/ijms23179540] [Reference Citation Analysis]
|
| 18 |
Samuel I, Ben-haroush Schyr R, Arad Y, Attali T, Azulai S, Bergel M, Halfon A, Hefetz L, Hirsch T, Israeli H, Lax N, Nitzan K, Sender D, Sweetat S, Okun E, Rosenmann H, Ben-zvi D. Sleeve Gastrectomy Reduces Glycemia but Does Not Affect Cognitive Impairment in Lean 5xFAD Mice. Front Neurosci 2022;16:937663. [DOI: 10.3389/fnins.2022.937663] [Reference Citation Analysis]
|
| 19 |
Campbell JM. Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts. Nutrients 2022;14:3231. [PMID: 35956406 DOI: 10.3390/nu14153231] [Reference Citation Analysis]
|
| 20 |
Sakamuri SS, Sure VN, Kolli L, Evans WR, Sperling JA, Bix GJ, Wang X, Atochin DN, Murfee WL, Mostany R, Katakam PV. Aging related impairment of brain microvascular bioenergetics involves oxidative phosphorylation and glycolytic pathways. J Cereb Blood Flow Metab 2022;42:1410-24. [PMID: 35296173 DOI: 10.1177/0271678X211069266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 21 |
Solís Herrera A. Oxygen Tissue Levels as an Effectively Modifiable Factor in Alzheimer’s Disease Improvement. Neuropsychology of Dementia [Working Title] 2022. [DOI: 10.5772/intechopen.106331] [Reference Citation Analysis]
|
| 22 |
Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A. GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight. Cells 2022;11:2023. [DOI: 10.3390/cells11132023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Delventhal R, Wooder ER, Basturk M, Sattar M, Lai J, Bolton D, Muthukumar G, Ulgherait M, Shirasu-Hiza MM. Dietary restriction ameliorates TBI-induced phenotypes in Drosophila melanogaster. Sci Rep 2022;12:9523. [PMID: 35681073 DOI: 10.1038/s41598-022-13128-x] [Reference Citation Analysis]
|
| 24 |
Rummel NG, Butterfield DA. Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress. Antioxid Redox Signal 2022;36:1289-305. [PMID: 34416829 DOI: 10.1089/ars.2021.0177] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 25 |
Cimini FA, Perluigi M, Barchetta I, Cavallo MG, Barone E. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. Int J Mol Sci 2022;23:5574. [PMID: 35628384 DOI: 10.3390/ijms23105574] [Reference Citation Analysis]
|
| 26 |
Koklesova L, Mazurakova A, Samec M, Kudela E, Biringer K, Kubatka P, Golubnitschaja O. Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00281-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Mackenzie-gray Scott CA, Pelkey KA, Caccavano AP, Abebe D, Lai M, Black KN, Brown ND, Trevelyan AJ, Mcbain CJ. Resilient Hippocampal Gamma Rhythmogenesis and Parvalbumin-Expressing Interneuron Function Before and After Plaque Burden in 5xFAD Alzheimer’s Disease Model. Front Synaptic Neurosci 2022;14:857608. [DOI: 10.3389/fnsyn.2022.857608] [Reference Citation Analysis]
|
| 28 |
Kalia V, Niedzwiecki MM, Bradner JM, Lau FK, Anderson FL, Bucher ML, Manz KE, Schlotter AP, Fuentes ZC, Pennell KD, Picard M, Walker DI, Hu WT, Jones DP, Miller GW. Cross-species metabolomic analysis of tau- and DDT-related toxicity. PNAS Nexus 2022;1:pgac050. [PMID: 35707205 DOI: 10.1093/pnasnexus/pgac050] [Reference Citation Analysis]
|
| 29 |
González A, Calfío C, Churruca M, Maccioni RB. Glucose metabolism and AD: evidence for a potential diabetes type 3. Alzheimers Res Ther 2022;14:56. [PMID: 35443732 DOI: 10.1186/s13195-022-00996-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Martini AC, Gross TJ, Head E, Mapstone M. Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome. Neuron 2022:S0896-6273(22)00309-9. [PMID: 35472307 DOI: 10.1016/j.neuron.2022.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Zhang S, Zhao J, Quan Z, Li H, Qing H. Mitochondria and Other Organelles in Neural Development and Their Potential as Therapeutic Targets in Neurodegenerative Diseases. Front Neurosci 2022;16:853911. [DOI: 10.3389/fnins.2022.853911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Han G, Zhen W, Dai Y, Yu H, Li D, Ma T. Dihuang-Yinzi Alleviates Cognition Deficits via Targeting Energy-Related Metabolism in an Alzheimer Mouse Model as Demonstrated by Integration of Metabolomics and Network Pharmacology. Front Aging Neurosci 2022;14:873929. [DOI: 10.3389/fnagi.2022.873929] [Reference Citation Analysis]
|
| 33 |
Ishfaq M, Bashir N, Riaz SK, Manzoor S, Khan JS, Bibi Y, Sami R, Aljahani AH, Alharthy SA, Shahid R. Expression of HK2, PKM2, and PFKM Is Associated with Metastasis and Late Disease Onset in Breast Cancer Patients. Genes (Basel) 2022;13. [PMID: 35328104 DOI: 10.3390/genes13030549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Liu J, Amin N, Sproviero W, Arnold M, Batra R, Bonnechere B, Chiou Y, Fernandes M, Krumsiek J, Newby D, Nho K, Kim JP, Saykin AJ, Shi L, Winchester L, Yang Y, Nevado-holgado AJ, Kastenmüller G, Kaddurah-daouk RF, van Duijn CM. Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia.. [DOI: 10.1101/2022.02.25.22271530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Front Neurosci 2022;16:836605. [DOI: 10.3389/fnins.2022.836605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 36 |
Yao X, Zhang J, Lu Y, Deng Y, Zhao R, Xiao S. Myricetin Restores Aβ-Induced Mitochondrial Impairments in N2a-SW Cells. ACS Chem Neurosci 2022;13:454-63. [PMID: 35114083 DOI: 10.1021/acschemneuro.1c00591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Craven RJ, Frazier HN, Thibault O. Dependence of glucose transport on autophagy and GAPDH activity. Brain Res 2022;1776:147747. [PMID: 34864044 DOI: 10.1016/j.brainres.2021.147747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Beard E, Lengacher S, Dias S, Magistretti PJ, Finsterwald C. Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives. Front Physiol 2022;12:825816. [DOI: 10.3389/fphys.2021.825816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 39 |
Osmanovic Barilar J, Knezovic A, Homolak J, Babic Perhoc A, Salkovic-Petrisic M. Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease. Int J Mol Sci 2022;23:548. [PMID: 35008973 DOI: 10.3390/ijms23010548] [Reference Citation Analysis]
|
| 40 |
Liang L, Yan J, Huang X, Zou C, Chen L, Li R, Xie J, Pan M, Zou D, Liu Y. Identification of molecular signatures associated with sleep disorder and Alzheimer's disease. Front Psychiatry 2022;13:925012. [PMID: 35990086 DOI: 10.3389/fpsyt.2022.925012] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Elsadany M, Elghaish RA, Khalil AS, Ahmed AS, Mansour RH, Badr E, Elserafy M. Transcriptional Analysis of Nuclear-Encoded Mitochondrial Genes in Eight Neurodegenerative Disorders: The Analysis of Seven Diseases in Reference to Friedreich’s Ataxia. Front Genet 2021;12. [DOI: 10.3389/fgene.2021.749792] [Reference Citation Analysis]
|
| 42 |
Saik OV, Klimontov VV. Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks. Int J Mol Sci 2021;22:12419. [PMID: 34830301 DOI: 10.3390/ijms222212419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 43 |
Song J, Yang X, Zhang M, Wang C, Chen L. Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease. J Alzheimers Dis 2021;84:557-78. [PMID: 34602474 DOI: 10.3233/JAD-210595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Parkhitko AA, Wang L, Filine E, Jouandin P, Leshchiner D, Binari R, Asara JM, Rabinowitz JD, Perrimon N. A genetic model of methionine restriction extends Drosophila health- and lifespan. Proc Natl Acad Sci U S A 2021;118:e2110387118. [PMID: 34588310 DOI: 10.1073/pnas.2110387118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 45 |
Deolankar SC, Patil AH, Rex DAB, Subba P, Mahadevan A, Prasad TSK. Mapping Post-Translational Modifications in Brain Regions in Alzheimer's Disease Using Proteomics Data Mining. OMICS 2021;25:525-36. [PMID: 34255573 DOI: 10.1089/omi.2021.0054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Kalia V, Niedzwiecki MM, Bradner JM, Lau FK, Bucher ML, Manz KE, Fuentes ZC, Pennell KD, Picard M, Walker DI, Hu WT, Jones DP, Miller GW. Cross-species metabolomic analysis of DDT and Alzheimer’s disease-associated tau toxicity.. [DOI: 10.1101/2021.06.14.448355] [Reference Citation Analysis]
|
| 47 |
Zhang S, Lachance BB, Mattson MP, Jia X. Glucose metabolic crosstalk and regulation in brain function and diseases. Prog Neurobiol 2021;204:102089. [PMID: 34118354 DOI: 10.1016/j.pneurobio.2021.102089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 48 |
Bonomi CG, De Lucia V, Mascolo AP, Assogna M, Motta C, Scaricamazza E, Sallustio F, Mercuri NB, Koch G, Martorana A. Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias. Neurobiol Aging 2021;105:333-9. [PMID: 34171631 DOI: 10.1016/j.neurobiolaging.2021.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 49 |
Zhang X, Alshakhshir N, Zhao L. Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease. Front Neurosci 2021;15:662242. [PMID: 33994936 DOI: 10.3389/fnins.2021.662242] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 50 |
Tassone G, Kola A, Valensin D, Pozzi C. Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer's Disease. Life (Basel) 2021;11:386. [PMID: 33923275 DOI: 10.3390/life11050386] [Reference Citation Analysis]
|
| 51 |
Zheng M, Wang P. Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer's disease. 3 Biotech 2021;11:179. [PMID: 33927970 DOI: 10.1007/s13205-021-02738-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 52 |
Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease. Alzheimers Res Ther 2021;13:71. [PMID: 33794997 DOI: 10.1186/s13195-021-00814-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 53 |
Wang B, Huang M, Shang D, Yan X, Zhao B, Zhang X. Mitochondrial Behavior in Axon Degeneration and Regeneration. Front Aging Neurosci 2021;13:650038. [PMID: 33762926 DOI: 10.3389/fnagi.2021.650038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 54 |
Ashraf GM, Ebada MA, Suhail M, Ali A, Uddin MS, Bilgrami AL, Perveen A, Husain A, Tarique M, Hafeez A, Alexiou A, Ahmad A, Kumar R, Banu N, Najda A, Sayed AA, Albadrani GM, Abdel-Daim MM, Peluso I, Barreto GE. Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies. Oxid Med Cell Longev 2021;2021:4572471. [PMID: 33747345 DOI: 10.1155/2021/4572471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Budni J, Braga Brandão A, da Silva S, Lima Garcez M, Mina F, Bellettini-Santos T, Casagrande Zabot G, Behenck Medeiros E, Scaini G, de Oliveira J, Streck EL, Quevedo J. Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats. Metab Brain Dis 2021;36:1057-67. [PMID: 33616841 DOI: 10.1007/s11011-021-00682-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
